Company Profile
|
TC BioPharm (Holdings) plc
(NASDAQ: TCBP)
|
5:30 PM UTC, 07/03/24 | |||
|---|---|---|---|---|
| Last: $0.91 | Change: +0.02 | %Change: +1.87% | Volume: 63,816 | |
Detailed Quote
M = Million B = Billion
Price Performance
Management Effectiveness
Profitability
| Open: | $ 0.95 | Volume: | 63,816 | |
|---|---|---|---|---|
| High: | $ 0.96 | Yield(%) | 0.00 | |
| Low: | $ 0.86 | P/E Ratio (ttm): | n/a | |
| Dividend ($): | n/a | Market Cap ($): | 2.84M | |
| EPS ($) | -347.89 | Shares Out: | 3.20M |
| % Price Change (last 4 weeks): | -16.70 |
|---|---|
| % Price Change (last 13 weeks): | -29.82 |
| % Price Change (last 26 weeks): | -71.52 |
| % Price Change (last 52 weeks): | -91.26 |
| % Price Change (year to date): | -71.92 |
| Return on Equity (%): | -432.91 |
|---|---|
| Return on Assets (%): | -59.80 |
| Return on Invested Capital (%): | -196.35 |
| Gross Profit Margin (%): | n/a |
|---|---|
| Net Profit Margin (%): | n/a |
| Operating Profit Margin (%): | 0.00 |
Price & Volume
Company Information
Per Share Data
Valuation Ratios
Financial Strength
|
|
|
| 50-day Moving Average: | $1.14 |
|---|---|
| 200-day Moving Average: | $3.57 |
| Avg. Daily Vol. (last 50 days): | 1,132,855 |
| Avg. Daily Vol. (last 200 days): | 1,791,267 |
| 52-wk high: | $19.60 |
| 52-wk low: | $0.72 |
| Bid: | $0.86 |
| Ask: | $0.95 |
|
TC Biopharm (Holdings) Plc is a clinical-stage biopharmaceutical company, which engages in the development of novel immunotherapy products based on its proprietary allogeneic gamma delta T cell platform. The company was founded by Michael Leek and Angela Scott in 2013 and is headquartered in Motherwell, the United Kingdom.
|
|
TC BioPharm (Holdings) plc
Maxim Park 1 2 Parklands Way Holytown Motherwell NK ML1 4WR Phone: 44.141.433.7557 Fax: n/a http://www.tcbiopharm.com |
| Earnings (1year) ($): | n/a |
|---|---|
| Annual Dividend ($): | 0.00 |
| Current P/E Ratio (ttm): | n/a |
| Book Value ($): | 0.02 |
| Cash Flow ($): | -6.37 |
| Price/Earnings (x): | n/a |
|---|---|
| Price/Sales (x): | n/a |
| Price/Book (x): | 184.95 |
| Price/Cash Flow (x): | n/a |
| Quick Ratio (x): | 0.95 |
|---|---|
| Current Ratio (x): | 0.95 |
| LT Debt/Equity (x): | 55.71 |
| Total Debt/Equity (x): | 67.08 |
